Multidisciplinary management of stage II-III gastric and gastro-oesophageal junction cancer

Anna D. Wagner*, Florian Lordick, Heike Grabsch, Masanori Terashima, Mitsumi Terada, Takaki Yoshikawa, Narikazu Boku, Kozo Kataoka, Elizabeth C. Smyth, Murielle Mauer, Karin Haustermans, Markus H. Moehler

*Corresponding author for this work

Research output: Contribution to journal(Systematic) Review article peer-review

12 Citations (Web of Science)

Abstract

The aim of this manuscript is to discuss the viewpoint of the European Organisation for Research and Treatment of Cancer (EORTC) Gastric Cancer Taskforce and Japan Clinical Oncology Group (JCOG) Gastric Cancer Study Group on the current challenges in the multidisciplinary management of stage II-III gastric and gastro-oesophageal junction (GEJ) cancer. We seek to outline how these challenges are addressed in current trials of both groups. Key elements of future trials of EORTC and JCOG in this indication are described, and a joint vision on how multidisciplinary research of gastric and GEJ cancer patients should be organised is outlined. (C) 2019 The Authors. Published by Elsevier Ltd.

Original languageEnglish
Pages (from-to)67-76
Number of pages10
JournalEuropean Journal of Cancer
Volume124
DOIs
Publication statusPublished - Jan 2020

Keywords

  • ADENOCARCINOMA
  • ADJUVANT CHEMOTHERAPY
  • Adjuvant
  • CLINICAL-RESEARCH
  • Chemotherapy
  • EORTC
  • EUROPEAN ORGANIZATION
  • Gastric
  • Immunotherapy
  • JCOG
  • MISMATCH REPAIR DEFICIENCY
  • OPEN-LABEL
  • PERIOPERATIVE CHEMOTHERAPY
  • Perioperative
  • RANDOMIZED PHASE-II
  • TRIAL DESIGN
  • PLUS OXALIPLATIN

Cite this